These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20007759)

  • 21. Additive effectiveness of everolimus plus tamoxifen therapy in treatment of encapsulating peritoneal sclerosis.
    Huddam B; Azak A; Koçak G; Başaran M; Voyvoda N; Duranay M
    Ren Fail; 2012; 34(3):387-9. PubMed ID: 22263915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats.
    Pietsch H; Raschke M; Ellinger-Ziegelbauer H; Jost G; Walter J; Frenzel T; Lenhard D; Hütter J; Sieber MA
    Invest Radiol; 2011 Jan; 46(1):48-56. PubMed ID: 20938346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases.
    Tsushima Y; Kanal E; Thomsen HS
    Br J Radiol; 2010 Jul; 83(991):590-5. PubMed ID: 20413447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients.
    Alscher DM; Braun N; Biegger D; Fritz P
    Am J Kidney Dis; 2007 Mar; 49(3):452-61. PubMed ID: 17336707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
    Gupta A; Shamseddin MK; Khaira A
    Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
    Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract]   [Full Text] [Related]  

  • 29. [Nephrogenic systemic fibrosis].
    Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
    G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is your diagnosis. Nephrogenic systemic fibrosis.
    Zaleski L; Xia Y; Cho S
    Cutis; 2011 Jan; 87(1):13, 19-20. PubMed ID: 21323094
    [No Abstract]   [Full Text] [Related]  

  • 31. Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany.
    Latus J; Ulmer C; Fritz P; Rettenmaier B; Biegger D; Lang T; Ott G; Scharpf C; Kimmel M; Steurer W; Alscher MD; Braun N
    Nephrol Dial Transplant; 2013 Apr; 28(4):1021-30. PubMed ID: 22734107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
    Richmond H; Zwerner J; Kim Y; Fiorentino D
    Arch Dermatol; 2007 Aug; 143(8):1025-30. PubMed ID: 17709661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C; Abraham JL
    J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of nephrogenic systemic fibrosis in liver transplantation patients.
    Chow DS; Bahrami S; Raman SS; Rotchel S; Sayre JW; Busuttil RW; Lu DS
    AJR Am J Roentgenol; 2011 Sep; 197(3):658-62. PubMed ID: 21862808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB; Jimenez SA
    J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Abu-Alfa AK
    Adv Chronic Kidney Dis; 2011 May; 18(3):188-98. PubMed ID: 21531325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P
    J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR; Jagirdar J
    J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
    Yerram P; Saab G; Karuparthi PR; Hayden MR; Khanna R
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):258-63. PubMed ID: 17699422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.
    Lindic J; Rupnik AT; Tomazic J; Skoberne A; Gucek A; Ferluga D; Pintar T; Ales A; Kovac D; Kveder R; Pajek J; Savicki-Ponikvar B; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):282-7. PubMed ID: 19695060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.